News
ADRX-0706 is a Nectin-4 ADC being evaluated in the Phase 1b portion of an ongoing Phase 1a/b clinical trial (NCT06036121) for the treatment of select advanced solid tumors, including cervical cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback